Dr Cheung, Wai Ting Lydia 張慧婷
Dr. Cheung received her BSc and PhD at The University of Hong Kong. She obtained further training in cancer genomics research as a post-doctoral fellow in the MD Anderson Cancer Center (Houston, US) and was then promoted to instructor in the same Institute.
She is presently an assistant professor in the School of Biomedical Sciences at the Faculty of Medicine. The major focus of her research is functional characterization of genomics abnormalities in cancers, with a goal of ultimately devising the optimal therapeutic strategies for cancer patients. Dr. Cheung has published in Cancer Cell, Cancer Discovery, Nature Communications, Genome Research, eLife, Cancer Research and Onocgene. She is the first to comprehensively characterize PI3K pathway aberrations in endometrial cancer. The findings were published in high impact journal Cancer Discovery and the paper is one of the most cited articles of the journal. Her other paper in Cancer Cell demonstrates that mutations in cancer patients can be neomorphs (gain of novel function) that activate unexpected pathways and are functionally distinct from the wild-type gene. This revolutionizes the concepts underlying personalized cancer therapy where the impact of each specific mutation in a cancer gene has to be considered rather than the cancer gene alone. The laboratory has recently revealed that different PI3K isoforms induce distinct signaling and functional consequences. Dr. Cheung has also received multiple grants and awards in Hong Kong and US.
|Awardees||Award Date||Honours / Awards / Prizes||Category|
|2023-03-08||Outstanding Young Researcher Award||Research Achievement|
|2020-09-01||Faculty Outstanding Research Output Award: HKU Li Ka Shing Faculty of Medicine||Research Achievement|
|2020-09-01||Excellent Young Scientists Fund (Hong Kong and Macau): National Natural Science Foundation of China||Research Achievement|
|2016-09-01||Travel award, U21 Workshop for Early Career Researchers: Universitas 21 (U21) and HKU||Research Achievement|
|2017-12-01||2017 USCACA & AFCR Scholar Awards: US Chinese Anti-Cancer Association (USCACA)Asian Fund for Cancer Research Limited (AFCR)||Research Achievement|
|Term Period||Position||Professional Societies|
|12/2016 to present||Member||Shenzhen Institute of Research and Innovation (SIRI)|
|07/2016 to present||Member||Hong Kong Society of Endocrinology, Metabolism and Reproduction|
|01/2011 to present||Active Member||American Association for Cancer Research|
Are You Missing Publications, Invited Lectures? Click Me.